Reyyan Gokcen Iscan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reyyan Gokcen Iscan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Sultan Seren Karakuş
Department of Gynecology and Obstetrics, Zeynep Kamil Women and Children Diseases Training and Research Hospital, University of Health Sciences, Istanbul 34668, Türkiye
3 shared publications - Önder Tosun
Department of Gynecology and Obstetrics, Zeynep Kamil Women and Children Diseases Training and Research Hospital, University of Health Sciences, Istanbul 34668, Türkiye
3 shared publications - Cetin Kilicci
Department of Obstetrics and Gynecology Zeynep Kamil Women and Children Diseases Training and Research Hospital Istanbul Turkey
2 shared publications - Mine Guray Uzun
Department of Gynecologic Oncology, Zeynep Kamil Women and Children Diseases Training and Research Hospital, University of Health Sciences, Istanbul 34668, Türkiye
2 shared publications - Muserref Banu Yilmaz
Department of Gynecology and Obstetrics, Zeynep Kamil Women and Children Diseases Training and Research Hospital, University of Health Sciences, Istanbul 34668, Türkiye
2 shared publications - Pınar Kumru
Department of Gynecology and Obstetrics, Zeynep Kamil Women and Children Diseases Training and Research Hospital, University of Health Sciences, Istanbul 34668, Türkiye
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 6977
Clinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder
Background/Objective: Intradetrusor onabotulinumtoxinA is an established treatment for refractory idiopathic overactive bladder (OAB); however, data on predictors of treatment response and patient management after the initial injection are limited. This study evaluated the clinical outcomes, safety, factors associated with treatment failure, and retreatment pathways following intradetrusor onabotulinumtoxinA in women with refractory idiopathic OAB. Methods: This retrospective cohort study included 41 women with refractory idiopathic OAB treated with 100 U intradetrusor onabotulinumtoxinA between November 2022 and January 2026. Efficacy was assessed using 3-day bladder diaries, validated patient-reported outcome measures (UDI-6, IIQ-7, and OAB-V8), and the Treatment Benefit Scale (TBS). Safety outcomes, factors associated with treatment failure, retreatment preferences, and subsequent management strategies were analyzed. Results: Significant improvements were observed in daytime frequency, urgency episodes, urgency urinary incontinence episodes, and validated patient-reported outcome measures (all p < 0.001). Treatment success according to the TBS was achieved in 68.3% and 46.3% of patients at 12 and 24 weeks, respectively. Diffuse bladder trabeculation was independently associated with treatment failure at 12 weeks (aOR 11.90, 95% CI 1.99–71.14; p = 0.007), whereas no significant independent association was observed at 24 weeks. Urinary tract infection occurred in 19.5% of patients, and temporary clean intermittent catheterization was required in one patient (2.4%). By postoperative week 24, 53.7% of patients declined repeat treatment, most commonly because of inadequate symptom improvement (77.3%). Among those declining reinjection, 59.1% resumed or continued pharmacological therapy. Conclusions: Intradetrusor injection of 100 U onabotulinumtoxinA was associated with significant improvement and acceptable safety in women with refractory idiopathic OAB. Diffuse bladder trabeculation may help identify patients at risk of poor treatment response, warranting further validation in larger patient cohorts. Documenting retreatment decisions and management provides real-world evidence that may support long-term counseling and decision-making.
- 9 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 6977
Open AccessClinical Outcomes and Retreatment Pathways Following Intradetrusor OnabotulinumtoxinA in Women with Refractory Idiopathic Overactive Bladder
Background/Objective: Intradetrusor onabotulinumtoxinA is an established treatment for refractory idiopathic overactive bladder (OAB); however, data on predictors of treatment response and patient management after the initial injection are limited. This study evaluated the clinical outcomes, safety, factors associated with treatment failure, and retreatment pathways following intradetrusor onabotulinumtoxinA in women with refractory idiopathic OAB. Methods: This retrospective cohort study included 41 women with refractory idiopathic OAB treated with 100 U intradetrusor onabotulinumtoxinA between November 2022 and January 2026. Efficacy was assessed using 3-day bladder diaries, validated patient-reported outcome measures (UDI-6, IIQ-7, and OAB-V8), and the Treatment Benefit Scale (TBS). Safety outcomes, factors associated with treatment failure, retreatment preferences, and subsequent management strategies were analyzed. Results: Significant improvements were observed in daytime frequency, urgency episodes, urgency urinary incontinence episodes, and validated patient-reported outcome measures (all p < 0.001). Treatment success according to the TBS was achieved in 68.3% and 46.3% of patients at 12 and 24 weeks, respectively. Diffuse bladder trabeculation was independently associated with treatment failure at 12 weeks (aOR 11.90, 95% CI 1.99–71.14; p = 0.007), whereas no significant independent association was observed at 24 weeks. Urinary tract infection occurred in 19.5% of patients, and temporary clean intermittent catheterization was required in one patient (2.4%). By postoperative week 24, 53.7% of patients declined repeat treatment, most commonly because of inadequate symptom improvement (77.3%). Among those declining reinjection, 59.1% resumed or continued pharmacological therapy. Conclusions: Intradetrusor injection of 100 U onabotulinumtoxinA was associated with significant improvement and acceptable safety in women with refractory idiopathic OAB. Diffuse bladder trabeculation may help identify patients at risk of poor treatment response, warranting further validation in larger patient cohorts. Documenting retreatment decisions and management provides real-world evidence that may support long-term counseling and decision-making.
- 12 June 2026
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- p. 1-17
Can β-hCG in uterine cavity lavage serve as a differential diagnostic tool for pregnancies of unknown location? Insights from a prospective study
Objectives: This prospective study aimed to evaluate whether β-human chorionic gonadotropin (β-hCG) levels in uterine cavity lavage fluid can serve as a diagnostic tool to differentiate ectopic pregnancy from failed intrauterine pregnancy in patients with pregnancy of unknown location (PUL). Design: This prospective interventional study was conducted at a tertiary referral center, enrolling a total of 113 hemodynamically stable patients with PUL. Materials and Methods: All enrolled patients underwent endometrial aspiration (EA), which was performed using a flexible Karman cannula to obtain tissue samples for histopathological examination. Based on histopathological results combined with clinical follow-up data, participants were subsequently categorized into two groups: those diagnosed with ectopic pregnancy and those with failed intrauterine pregnancy. Prior to performing EA, uterine lavage was performed to collect fluid samples from the endometrial cavity, and β-human chorionic gonadotropin levels were quantitatively measured in the lavage specimens. The primary outcome measure was the comparison of lavage β-human chorionic gonadotropin concentrations between the ectopic and failed intrauterine pregnancy groups, with the intent to establish a diagnostic cutoff value for clinical application. Secondary outcome measures included comparisons of serum β-human chorionic gonadotropin levels, endometrial thickness assessed via imaging, and clinical and demographic parameters between the groups. Results After exclusion criteria and incomplete data removal, 103 patients were included in the final analysis, comprising 81 individuals diagnosed with ectopic pregnancy and 22 with failed intrauterine pregnancies. Statistical analysis showed that the mean age was significantly higher in the failed intrauterine pregnancy group versus the ectopic pregnancy group (p = 0.03), while other demographic and clinical variables did not differ significantly between the groups. β-human chorionic gonadotropin concentrations in uterine lavage fluid were lower in the ectopic group compared to the failed intrauterine pregnancy group. This difference was significant in absolute terms (mean ± SD: 122.78 ± 115.41 mIU/mL vs. 321.09 ± 495.19 mIU/mL, p = 0.008) and after normalization to total protein content in the lavage fluid (100.67 ± 208.19 mIU/mg vs. 294.32 ± 510.69 mIU/mg, p = 0.001). In contrast, serum β-human chorionic gonadotropin levels and endometrial thickness did not show statistically significant differences between the two groups. Conclusions Lavage β-human chorionic gonadotropin appears promising as a tool for early pregnancy of unknown location assessment by identifying the pregnancy location. This standardized methodology could expedite the diagnosis of high-risk pregnancies through a less invasive approach, thereby enhancing ectopic pregnancy management. Further research is needed to improve accuracy.
- 12 June 2026
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- p. 1-17
Can β-hCG in uterine cavity lavage serve as a differential diagnostic tool for pregnancies of unknown location? Insights from a prospective study
Objectives: This prospective study aimed to evaluate whether β-human chorionic gonadotropin (β-hCG) levels in uterine cavity lavage fluid can serve as a diagnostic tool to differentiate ectopic pregnancy from failed intrauterine pregnancy in patients with pregnancy of unknown location (PUL). Design: This prospective interventional study was conducted at a tertiary referral center, enrolling a total of 113 hemodynamically stable patients with PUL. Materials and Methods: All enrolled patients underwent endometrial aspiration (EA), which was performed using a flexible Karman cannula to obtain tissue samples for histopathological examination. Based on histopathological results combined with clinical follow-up data, participants were subsequently categorized into two groups: those diagnosed with ectopic pregnancy and those with failed intrauterine pregnancy. Prior to performing EA, uterine lavage was performed to collect fluid samples from the endometrial cavity, and β-human chorionic gonadotropin levels were quantitatively measured in the lavage specimens. The primary outcome measure was the comparison of lavage β-human chorionic gonadotropin concentrations between the ectopic and failed intrauterine pregnancy groups, with the intent to establish a diagnostic cutoff value for clinical application. Secondary outcome measures included comparisons of serum β-human chorionic gonadotropin levels, endometrial thickness assessed via imaging, and clinical and demographic parameters between the groups. Results After exclusion criteria and incomplete data removal, 103 patients were included in the final analysis, comprising 81 individuals diagnosed with ectopic pregnancy and 22 with failed intrauterine pregnancies. Statistical analysis showed that the mean age was significantly higher in the failed intrauterine pregnancy group versus the ectopic pregnancy group (p = 0.03), while other demographic and clinical variables did not differ significantly between the groups. β-human chorionic gonadotropin concentrations in uterine lavage fluid were lower in the ectopic group compared to the failed intrauterine pregnancy group. This difference was significant in absolute terms (mean ± SD: 122.78 ± 115.41 mIU/mL vs. 321.09 ± 495.19 mIU/mL, p = 0.008) and after normalization to total protein content in the lavage fluid (100.67 ± 208.19 mIU/mg vs. 294.32 ± 510.69 mIU/mg, p = 0.001). In contrast, serum β-human chorionic gonadotropin levels and endometrial thickness did not show statistically significant differences between the two groups. Conclusions Lavage β-human chorionic gonadotropin appears promising as a tool for early pregnancy of unknown location assessment by identifying the pregnancy location. This standardized methodology could expedite the diagnosis of high-risk pregnancies through a less invasive approach, thereby enhancing ectopic pregnancy management. Further research is needed to improve accuracy.
- Open Access
GnRHa Triggering Versus hCG Triggering in PCOS Patients Who Undergo Fresh or FET Cycles: Is the King Fake or Real?
Background and Objectives: To evaluate the impact of gonadotropin-releasing hormone agonist (GnRHa) triggering compared to human chorionic gonadotropin (hCG) triggering on frozen–thawed and fresh embryo transfer outcomes in patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF). Materials and Methods: This retrospective cohort study analyzed 267 IVF cycles of 261 PCOS patients treated with GnRH antagonist protocols. Patients were divided into three groups: GnRHa-triggered frozen–thawed embryo transfer (ET) (n = 126), hCG-triggered frozen–thawed ET (n = 68), and hCG-triggered fresh ET (n = 73). Baseline characteristics, stimulation parameters, and cycle outcomes were compared between groups. A binary logistic regression analysis was established to identify independent predictors of clinical pregnancy. Results: The GnRHa-triggered group had significantly higher numbers of retrieved oocytes, mature (MII) oocytes, and fertilized oocytes compared to both hCG-triggered groups (p < 0.001). The number of obtained embryos and frozen embryos (good-quality embryos) was highest in the GnRHa group (p < 0.001). However, clinical pregnancy rates were comparable between the groups with a similar number and grade of transferred embryos (32.53%, 38.23%, and 32.87%, respectively). Multivariate regression analysis revealed that the grade of the transferred embryo was a significant predictor of clinical pregnancy (p = 0.034). Conclusions: This study provides insights into different triggering strategies for final oocyte maturation in PCOS patients. GnRH-agonist-triggered frozen–thawed cycles showed comparable clinical pregnancy outcomes to those of hCG-triggered cycles, with a potentially lower OHSS risk. The findings suggest that individualized triggering approaches based on patient characteristics and OHSS risk may be beneficial for PCOS patients undergoing IVF.
Open AccessGnRHa Triggering Versus hCG Triggering in PCOS Patients Who Undergo Fresh or FET Cycles: Is the King Fake or Real?
Background and Objectives: To evaluate the impact of gonadotropin-releasing hormone agonist (GnRHa) triggering compared to human chorionic gonadotropin (hCG) triggering on frozen–thawed and fresh embryo transfer outcomes in patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF). Materials and Methods: This retrospective cohort study analyzed 267 IVF cycles of 261 PCOS patients treated with GnRH antagonist protocols. Patients were divided into three groups: GnRHa-triggered frozen–thawed embryo transfer (ET) (n = 126), hCG-triggered frozen–thawed ET (n = 68), and hCG-triggered fresh ET (n = 73). Baseline characteristics, stimulation parameters, and cycle outcomes were compared between groups. A binary logistic regression analysis was established to identify independent predictors of clinical pregnancy. Results: The GnRHa-triggered group had significantly higher numbers of retrieved oocytes, mature (MII) oocytes, and fertilized oocytes compared to both hCG-triggered groups (p < 0.001). The number of obtained embryos and frozen embryos (good-quality embryos) was highest in the GnRHa group (p < 0.001). However, clinical pregnancy rates were comparable between the groups with a similar number and grade of transferred embryos (32.53%, 38.23%, and 32.87%, respectively). Multivariate regression analysis revealed that the grade of the transferred embryo was a significant predictor of clinical pregnancy (p = 0.034). Conclusions: This study provides insights into different triggering strategies for final oocyte maturation in PCOS patients. GnRH-agonist-triggered frozen–thawed cycles showed comparable clinical pregnancy outcomes to those of hCG-triggered cycles, with a potentially lower OHSS risk. The findings suggest that individualized triggering approaches based on patient characteristics and OHSS risk may be beneficial for PCOS patients undergoing IVF.
- 7 October 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (3) , 777-784
Laparoscopic Meshless Lateral Suspension in Patients with Advanced Stage Pelvic Organ Prolapse. A Prospective Cohort Study with a Median 36-Month Follow-Up
Introduction and Hypothesis Laparoscopic lateral suspension with mesh is an effective technique for apical prolapse repair. In this study, we aimed to evaluate the outcomes of meshless laparoscopic lateral suspension in patients with advanced stage pelvic organ prolapse. Methods This study was conducted prospectively on patients with apical defects who had stage 3 or greater pelvic organ prolapse. The cervix or vaginal cuff was below the hymen in all patients. POP-Q measurements were performed. Meshless laparoscopic suspension was performed with a nonabsorbable suture. Perioperative complications were also noted. The patients were followed up. Late postoperative results at 36 months were noted. Objective cure was defined as POP-Q stage < II in any compartment. Objective cure rate and pelvic organ prolapse quantification system score were the main outcome measures. Results A total of 32 patients were included in the study. The mean age was 54.97 ± 13.31 years. Laparoscopic meshless suspension was performed in all patients under general anesthesia. Total laparoscopic hysterectomy was performed in 25 patients (78.1%). Other concomitant procedures were uterosacral ligament plication, laparoscopic cystocele repair, retropubic TVT, BURCH colposuspension, and posterior colporaphy. The median pelvic organ prolapse quantification score was significantly lower at 36 months postoperative. We calculated the objective cure rate for meshless laparoscopic lateral suspension for apical defects to be 81.3% at the 36-month follow-up. Conclusions Laparoscopic meshless lateral suspension is a novel technique with promising initial results that require further evaluation.
- 7 October 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (3) , 777-784
Laparoscopic Meshless Lateral Suspension in Patients with Advanced Stage Pelvic Organ Prolapse. A Prospective Cohort Study with a Median 36-Month Follow-Up
Introduction and Hypothesis Laparoscopic lateral suspension with mesh is an effective technique for apical prolapse repair. In this study, we aimed to evaluate the outcomes of meshless laparoscopic lateral suspension in patients with advanced stage pelvic organ prolapse. Methods This study was conducted prospectively on patients with apical defects who had stage 3 or greater pelvic organ prolapse. The cervix or vaginal cuff was below the hymen in all patients. POP-Q measurements were performed. Meshless laparoscopic suspension was performed with a nonabsorbable suture. Perioperative complications were also noted. The patients were followed up. Late postoperative results at 36 months were noted. Objective cure was defined as POP-Q stage < II in any compartment. Objective cure rate and pelvic organ prolapse quantification system score were the main outcome measures. Results A total of 32 patients were included in the study. The mean age was 54.97 ± 13.31 years. Laparoscopic meshless suspension was performed in all patients under general anesthesia. Total laparoscopic hysterectomy was performed in 25 patients (78.1%). Other concomitant procedures were uterosacral ligament plication, laparoscopic cystocele repair, retropubic TVT, BURCH colposuspension, and posterior colporaphy. The median pelvic organ prolapse quantification score was significantly lower at 36 months postoperative. We calculated the objective cure rate for meshless laparoscopic lateral suspension for apical defects to be 81.3% at the 36-month follow-up. Conclusions Laparoscopic meshless lateral suspension is a novel technique with promising initial results that require further evaluation.
- Open Access
- 18 February 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 65-74
Which urinary incontinence inquiry form should be used in women with urinary incontinence?
Which urinary incontinence inquiry form should be used in women with urinary incontinence? - Turkish Journal of Obstetrics and Gynecology
- 18 February 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 65-74
Open AccessWhich urinary incontinence inquiry form should be used in women with urinary incontinence?
Which urinary incontinence inquiry form should be used in women with urinary incontinence? - Turkish Journal of Obstetrics and Gynecology